< Products Center_Dawnsail Biotech Co. Ltd. Feline Cardiac Troponin-I (fcTnI)_Dawnsail Biotech Co. Ltd.

Tel:0573-82725861 Email:customer@dawnsailbio.com

Copyright © Jiaxing Dawnsail Biotech Co., Ltd.    

浙ICP备14014747号  Powered by 300.cn

Feline Cardiac Troponin-I (fcTnI)

basic information


fcTnI is widely accepted as one of the most sensitive and specific biomarkers for feline cardiomyocyte injury, and is also the main biomarkers in rapid diagnosis of acute myocardial infraction (AMI) and acute coronary syndrome (ACS)

Quantitative immunofluorescent technology detects feline cTnI concentration

10 min rapid test

About Heart Disease

Feline heart disease usually begins with cardiomyopathy. Hypertrophic cardiomyopathy leads to heart failure, thrombus and myocardial injury. Many felines were failed to recover because of delayed detection and treatment.

cTnI concentration rises because of congestive heart failure and thromboembolism

Clinical Application

1: The gold standard for diagnosis of acute myocardial infraction:

2: Identification and diagnosis of various causes of chest pain

3: diagnosis and classification of ACS

4: The best marker for prognosis evaluation of ACS

5: The preferred marker for monitoring myocardial injury with the highest myocardial specificity

On a
Canine Cardiac Troponin-I (cTnI)
The next article
Canine NT-proBNP (BNP)